SCHEMBL7956697

SCHEMBL7956697

CN(C)CCNc1ccccc1-c1noc(-c2ccccc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.49
NPC1 O15118 6/20 0.49
SMN1; SMN2 Q16637 6/20 0.49
TP53 P04637 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
ALDH1A1 P00352 2/20 0.49
SLC2A1 P11166 1/20 0.47
NR1H4 Q96RI1 3/20 0.46
NFKB1 P19838 3/20 0.43
NFKB2 Q00653 3/20 0.43
RELA Q04206 3/20 0.43
TLR9 Q9NR96 1/20 0.43
NCF1 P14598 2/20 0.43
MAPT P10636 3/20 0.43
MAPK1 P28482 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
KDM4E B2RXH2 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42
ACP1 P24666 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7956850 0.90 GPR55 (0.52) RAB9ANPC1SMN1; SMN2TP53L3MBTL1
SCHEMBL5736045 0.74 HTR7 (0.63) RAB9ANPC1SMN1; SMN2TP53L3MBTL1
SCHEMBL28925303 0.68 SMN1; SMN2 (0.77) RAB9ANPC1SMN1; SMN2TP53L3MBTL1
SCHEMBL7958685 0.68 NR1H4 (0.62) RAB9ANPC1SMN1; SMN2TP53ALDH1A1
SCHEMBL7958856 0.68 HTR7 (0.62) RAB9ANPC1SMN1; SMN2TP53L3MBTL1
SCHEMBL17226529 0.68 SLC2A1 (0.71) ALDH1A1SLC2A1TLR9NCF1KDM4E
SCHEMBL7957222 0.68 HTR7 (0.53) RAB9ANPC1SMN1; SMN2TP53L3MBTL1
SCHEMBL4933326 0.67 SMN1; SMN2 (0.50) RAB9ANPC1SMN1; SMN2TP53L3MBTL1
SCHEMBL7956454 0.67 HTR7 (0.52) RAB9ANPC1SMN1; SMN2TP53L3MBTL1
Irampanel SCHEMBL678128 0.67 HTR7 (0.63) RAB9ANPC1SMN1; SMN2TP53L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277872-B1 ANTIISCHEMIC AGENTS; BRAIN DISORDERS BOEHRINGER INGELHEIM KG (DE) 2001-08-21 US disclosed